Streetbeat News

Products Services

AMZN

COIN

GM

MSFT

TSLA

Coinbase, GM, Amazon, Tesla, and Microsoft are the top five stocks on investors' radar after U.S. stocks dipped but recovered slightly in after-hours trading. Coinbase rose due to Bitcoin's new high and Argentina's pro-crypto president. GM plans to relaunch Robotaxi services after safety improvements. Amazon became the largest U.S. delivery service by volume. Tesla's Model Y is projected to be Europe's top-selling vehicle, and Microsoft's AI and cloud computing strength continue to attract investors.

Portfolio Pulse from Ramakrishnan M

November 28, 2023 | 4:04 am

TSLA

Tesla Inc (NASDAQ:TSLA) has increased the price of its Model Y Long Range in China for the third time in less than three weeks, with the latest hike being 2000 yuan (approximately $282). The vehicle's price is now 6500 yuan (around $916) higher than at the start of November, although it remains cheaper than its October 2022 pricing.

Portfolio Pulse from Anan Ashraf

November 28, 2023 | 3:24 am

BTCUSD

Robert F. Kennedy Jr., an Independent Presidential candidate, discussed the risks of central bank digital currencies (CBDCs) on the 'What Bitcoin Did' podcast, highlighting their potential to infringe on personal freedoms. He warned that CBDCs could be tied to social credit scores, allowing governments to control individual spending. Kennedy endorsed Bitcoin as a 'elegant solution' for transactional freedom, emphasizing its independence from any governing entity and its role in promoting global freedom.

Portfolio Pulse from Benzinga Neuro

November 28, 2023 | 2:55 am

NFLX

Netflix Inc (NASDAQ:NFLX) has won the rights to a new comedy film, 'The Fifth Wheel,' starring Kim Kardashian, after a competitive bidding war. Kardashian, who has a significant social media following, will also serve as a producer and be involved in marketing the film. This move by Netflix comes despite former President Donald Trump's past comment calling Kardashian the 'most overrated celebrity.'

Portfolio Pulse from Chris Katje

November 28, 2023 | 12:19 am

SWTX

SpringWorks Therapeutics has received FDA approval for OGSIVEO (nirogacestat), making it the first and only approved treatment for adults with desmoid tumors. This marks a significant milestone for the company and offers a new therapeutic option for patients with this rare and often debilitating condition.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 11:05 pm

TSLA

Tesla Inc's (NASDAQ:TSLA) Model Y is on track to become the bestselling vehicle in Europe for 2023, having already sold 212,517 units in the first 10 months, leading the second place by 15,035 units. The Model Y's strong sales performance, making up 73% of Tesla's total European sales, could lead to it being the first electric vehicle, midsize car, premium car, and non-European car to achieve this status in the modern era. Tesla's stock has seen a significant increase, up over 115% year-to-date.

Portfolio Pulse from Chris Katje

November 27, 2023 | 10:01 pm

SCBFY

Standard Chartered Bank (China) has begun offering digital yuan exchange services, making it the first foreign bank to join China's CBDC pilot testing. The bank is collaborating with City Bank Clearing Services to provide access to the digital yuan's interconnection platform. China's digital yuan, or e-CNY, has seen significant adoption with $253.6 billion in transactions and 120 million wallets since 2020. The pilot is active in 26 cities and provinces, and the digital yuan is expected to enhance payment experiences and international financial market integration.

Portfolio Pulse from Khyathi Dalal

November 27, 2023 | 10:00 pm

SLRN

ACELYRIN is evaluating the future development path for Izokibep, including whether to continue trials with the current CRO or switch to a new one. The decision will be based on an ongoing evaluation and a planned audit.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:37 pm

SLRN

ACELYRIN has announced that its team identified and corrected execution errors in a Psoriatic Arthritis (PsA) trial. A programming error affected the dosing sequence, which has now been rectified.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:34 pm

SNES

SenesTech shares have risen following the announcement of the launch of their new product, Evolve Soft Bait, at Ace Hardware franchise locations in California.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 9:30 pm